Godfrey Barabona

Kumamoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Improving surgical patients' safety in African hospitals: exploring healthcare professionals' experiences of Phase 1 of the '5Rs to Rescue' programme.

Improving surgical patients' safety in African hospitals: exploring healthcare professionals' experiences of Phase 1 of the '5Rs to Rescue' programme.

Journal: International journal for quality in health care : journal of the International Society for Quality in Health Care

Published: March 09, 2026

Sociodemographic and Clinical Correlates of Markers of Immune Activation, Exhaustion and Platelet Activation among HIV-Infected Patients Initiating Antiretroviral Therapy in Dar es Salaam, Tanzania.

Sociodemographic and Clinical Correlates of Markers of Immune Activation, Exhaustion and Platelet Activation among HIV-Infected Patients Initiating Antiretroviral Therapy in Dar es Salaam, Tanzania.

Journal: Japanese journal of infectious diseases

Published: July 30, 2025

T-Cell Interferon Gamma Responses to SARS-CoV-2 Following Infection with/Without Vaccination in a Tanzanian Population.

T-Cell Interferon Gamma Responses to SARS-CoV-2 Following Infection with/Without Vaccination in a Tanzanian Population.

Journal: Infection and drug resistance

Published: April 29, 2025

Low-dose aspirin is not effective as an adjunct treatment for HIV infection among people living with HIV on dolutegravir-based antiretroviral therapy: A randomised double-blind, parallel-group placebo-controlled trial.

Low-dose aspirin is not effective as an adjunct treatment for HIV infection among people living with HIV on dolutegravir-based antiretroviral therapy: A randomised double-blind, parallel-group placebo-controlled trial.

Journal: PloS one

Published: February 06, 2025

Evaluation of a surrogate virus neutralization assay for detecting neutralizing antibodies against SARS-CoV-2 in an African population.

Evaluation of a surrogate virus neutralization assay for detecting neutralizing antibodies against SARS-CoV-2 in an African population.

Journal: Biology methods & protocols

Published: September 24, 2024

HIV viral suppression in the era of dolutegravir use: Findings from a national survey in Tanzania.

HIV viral suppression in the era of dolutegravir use: Findings from a national survey in Tanzania.

Journal: PloS one

Published: March 14, 2024

Factors Associated with Neutralizing Antibody Responses following 2-Dose and 3rd Booster Monovalent COVID-19 Vaccination in Japanese People Living with HIV.

Factors Associated with Neutralizing Antibody Responses following 2-Dose and 3rd Booster Monovalent COVID-19 Vaccination in Japanese People Living with HIV.

Journal: Viruses

Published: February 08, 2024

Evaluation of cross-neutralizing immunity following COVID-19 primary series vaccination during the Omicron surge in Tanzania.

Evaluation of cross-neutralizing immunity following COVID-19 primary series vaccination during the Omicron surge in Tanzania.

Journal: Journal of medical virology

Published: January 26, 2024

Neutralizing immunity against coronaviruses in Tanzanian health care workers.

Neutralizing immunity against coronaviruses in Tanzanian health care workers.

Journal: Scientific reports

Published: December 26, 2023

Relative resistance of patient-derived envelope sequences to SERINC5-mediated restriction of HIV-1 infectivity.

Relative resistance of patient-derived envelope sequences to SERINC5-mediated restriction of HIV-1 infectivity.

Journal: Journal of virology

Published: September 28, 2023

Hypertension and immune activation in antiretroviral therapy naïve people living with human immunodeficiency virus.

Hypertension and immune activation in antiretroviral therapy naïve people living with human immunodeficiency virus.

Journal: BMC infectious diseases

Published: July 21, 2023

Evaluation of Neutralizing Activity against Omicron Subvariants in BA.5 Breakthrough Infection and Three-Dose Vaccination Using a Novel Chemiluminescence-Based, Virus-Mediated Cytopathic Assay.

Evaluation of Neutralizing Activity against Omicron Subvariants in BA.5 Breakthrough Infection and Three-Dose Vaccination Using a Novel Chemiluminescence-Based, Virus-Mediated Cytopathic Assay.

Journal: Microbiology spectrum

Published: June 13, 2023

Showing 1-12 of 23

Last Updated: 09/26/2026